Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul:154:107719.
doi: 10.1016/j.leukres.2025.107719. Epub 2025 May 27.

Treatment strategies and survival after ruxolitinib discontinuation in myelofibrosis patients: The Italian RUX-MF multicenter study

Francesca Palandri  1 , Massimo Breccia  2 , Erika Morsia  3 , Elena M Elli  4 , Giulia Benevolo  5 , Mario Tiribelli  6 , Eloise Beggiato  7 , Mirko Farina  8 , Giovanni Caocci  9 , Novella Pugliese  10 , Alessia Tieghi  11 , Monica Crugnola  12 , Gianni Binotto  13 , Francesco Cavazzini  14 , Alessandro Isidori  15 , Alessandra Dedola  16 , Emilia Scalzulli  2 , Alessia Moioli  17 , Fabrizio Cavalca  4 , Santino Caserta  18 , Andrea Duminuco  19 , Bruno Martino  20 , Roberto M Lemoli  21 , Daniela Cilloni  22 , Monica Bocchia  23 , Fabrizio Pane  10 , Florian H Heidel  24 , Massimiliano Bonifacio  17 , Giuseppe A Palumbo  25 , Filippo Branzanti  26 , Alessandra Iurlo  27 , Elisabetta Abruzzese  28
Affiliations

Treatment strategies and survival after ruxolitinib discontinuation in myelofibrosis patients: The Italian RUX-MF multicenter study

Francesca Palandri et al. Leuk Res. 2025 Jul.
No abstract available

Keywords: Myelofibrosis; Propensity score matching; Ruxolitinib; Second-line therapy.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest Francesca Palandri participated in the speakers bureau and advisory board of Novartis, BMS, AOP, Sierra Oncology, Incyte, Telios, Abbvie, Constellation-Morphosys, Sobi and GSK. Giulia Benevolo reports honoraria from Novartis, Janssen, Amgen, Takeda, and BMS. Massimo Breccia reports honoraria from Novartis, BMS, Pfizer, Incyte. Massimiliano Bonifacio reports honoraria from Novartis, BMS, Pfizer, and Incyte. Monica Crugnola reports honoraria from Novartis and Amgen. Gianni Binotto reports honoraria from Novartis, Incyte, BMS-Celgene, and Pfizer. Roberto M. Lemoli reports honoraria from Jazz, Pfizer, AbbVie, BMS, Sanofi, and StemLine. Fabrizio Pane reports honoraria from Incyte, Novartis, Jazz, BMS-Celgene, Amgen, and Gilead. Giuseppe A. Palumbo reports consultancy and honoraria from Abbvie, AOP, AstraZeneca, BMS, Incyte, GSK, Morphosys, and Novartis. Mario Tiribelli reports honoraria from and has served on speakers’ bureaus for Novartis, BMS, Pfizer, and Incyte.

LinkOut - more resources